Loading...
NKGen Biotech, Inc. Common Stock
NKGN•NASDAQ
Healthcare
Biotechnology
$0.06
$0.00(0.00%)
U.S. Market opens in 54h 25mNKGen Biotech, Inc. Common Stock (NKGN) AI-Powered Stock Analysis
See how NKGen Biotech, Inc. Common Stock scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerNKGen Biotech, Inc. Common Stock (NKGN) Stock Overall Grade
NKGen Biotech, Inc. Common Stock’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to NKGen Biotech, Inc. Common Stock's overall stock rating.
Forecast
C+Score
53/100Financial Growth
CScore
40/100Fundamental Growth
BScore
69/100Key Ratios
B+Score
70/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
C+Score
50/100NKGen Biotech, Inc. Common Stock (NKGN) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 53/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (69/100, B) highlight its stability, while Key Ratios (70/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each NKGen Biotech, Inc. Common Stock stock grade, including financials, comparisons, and forecasts.